Work

The Oral JAK2/IRAK1 Inhibitor Pacritinib Demonstrates Spleen Volume Reduction in Myelofibrosis Patients Independent of JAK2V617F Allele Burden

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-127609

Authors: Srdan Verstovsek, Bart L. Scott, Jason A Taylor, John Mascarenhas

Institutions: The University of Texas MD Anderson Cancer Center, University of Washington, CTI BioPharma (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2983287333

Cites:

Cited by: 6

Related to: 10